CONTACTS 

SUBJECTS
Lousy Weak Feeling Bad 3 Days After Chemotherapy Went to Exercise Cl

1103 -
1103 -    ..
1104 - Summary/Objective
1105 -
110501 - Follow up ref SDS 15 0000, ref SDS 14 0000.
110502 -
110503 - Millie is not feeling well this morning due to effects of chemotherapy
110504 - treatments begun on 060721. ref SDS 14 0001
110506 -  ..
110507 - Yesterday, there was a bowel accident while driving to go shopping.
110508 - Had to rush home.  We got everything cleaned up, and then got back in
110509 - the car and accomplished goals to go shopping.
110511 -  ..
110512 - This morning despite feeling really lousy from treatment with Taxotere
110513 - and capecitabine (Xeloda), and reported previously on 050712,
110514 - ref SDS 10 QB7K, and earlier on 050520, when dosage of treatment was
110515 - reduced to make chemotherapy tolerable, ref SDS 8 NT3I, decided to go
110516 - to exercise class again today and do as much as possible.  Will do
110517 - more shopping on the way home, following the doctor's advice to keep
110518 - active, during chemotherapy treatments, reviewed on 060722.
110519 - ref SDS 15 KT8G
110520 -
110522 -  ..
1106 -
1107 -
1108 - 1230
1109 -
110901 - Millie resting.
110902 -
110903 -
110904 -
110905 -
1110 -

SUBJECTS
Diary Side Effects Chemotherapy Phase 2 Taxotere Capecitabine (Xelod

1303 -
130401 -  ..
130402 - Effectiveness Treatment IBC Recurrence Left Breast
130403 - Xeloda Taxotere Effectiveness Treating IBC and Side Effects
130404 - Chemotherapy Taxotere Capecitabine Effectiveness Treating IBC
130405 - Case Study Side Effects Chemotherapy Taxotere Capecitabine Xeloda
130406 -
130407 - On 050415 Zan, the Pharmacist, recommended keeping a diary to report
130408 - chemotherapy effectiveness that assists the doctor in adjusting
130409 - treatment. ref SDS 6 2W6I  The record on 050422 summarizes Millie's
130410 - diary of side efforts for treatment last year with Taxotere and
130411 - capecitabine (Xeloda). ref SDS 7 VE68
130413 -  ..
130414 - Today, Vickie at Kaiser called Millie to ask about side effects.
130416 -  ..
130417 - This record will maintain a similar summary of diaries on coping with
130418 - side effects from the 2nd phase of treatment with Taxoter and
130419 - capecitabine (Xeloda), prescribed during a meeting at Kaiser on
130420 - 060711, ref SDS 12 PF3O, and begun on 060721. ref SDS 14 0001
130421 -
130422 -        1.  Tired wobbly after first
130423 -            treatment; slightly disoriented
130424 -            from combination of drugs;
130425 -            could not drive home; went to
130426 -            bed after dinner about
130427 -            1800............................. 060721, ref SDS 14 F54N
130429 -             ..
130430 -        2.  Millie went to exercise class;
130431 -            made potato salad and had
130432 -            dinner with her family and
130433 -            grandchildren.................... 060722, ref SDS 15 0001
130435 -             ..
130436 -        3.  Son reports doctor found genetic
130437 -            cause of pulmonary emboli
130438 -            recurrence on 060714; may relate
130439 -            to Millie's treatment if
130440 -            Coumadin prescribed.............. 060722, ref SDS 15 3D9T
130442 -             ..
130443 -        4.  Went shopping; had physical
130444 -            difficulties..................... 060723, ref SDS 0 UF6N
130446 -             ..
130447 -        5.  Feeling lousy; went to exercise
130448 -            class, and then shopping;
130449 -            took nap from 1230 to
130450 -            1600............................. 060724, ref SDS 0 LG7I
130452 -             ..
130453 -        6.  Kaiser requested feedback on
130454 -            side effects of chemotherapy..... 060724, ref SDS 17 0001
130455 -            submitted this diary per
130456 -            guidance from Pharmacist......... 060724, ref SDS 0 QX8K
130458 -             ..
130459 -        7.  Work - going into office;
130460 -            feeling stronger this morning
130461 -            4 days after starting
130462 -            chemotherapy..................... 060725, ref SDS 18 0001
130464 -             ..
130465 -        8.  Energetic, positive mental
130466 -            frame 7 days after starting
130467 -            Taxotere, and continuing to
130468 -            take 1500 MG capecitabine
130469 -            (Xeloda) per day................. 060726, ref SDS 19 0001
130471 -             ..
130472 -        9.  Physically recovered from side
130473 -            effects 1st cycle chemotherapy
130474 -            treating IBC relapse; going to
130475 -            exercise class, strong,
130476 -            energetic........................ 060806, ref SDS 20 7Q8H,
130478 -             ..
130479 -       10.  Feeling lousy at work 3 days
130480 -            after treatment on 060814
130481 -            switched to Monday for
130482 -            experiment; body aching all
130483 -            over; eyes tearing, and nose
130484 -            running.......................... 060817, ref SDS 21 7Q8H
130486 -             ..
130487 -       11.  Still not recovered from chemo
130488 -            side effects 5 days ago on
130489 -            060814; day off work; slept
130490 -            most of the day; went to dinner
130491 -            with friend, home by 1930, and
130492 -            asleep at 2018................... 060818, ref SDS 21 7Q8H
130494 -             ..
130495 -       12.  Side effects moderate report
130496 -            to pharmacist; dry hands, loose
130497 -            bowels, no diarrea; nausea,
130498 -            queazy stomache.................. 060908, ref SDS 22 QU8K
130500 -             ..
130501 -       13.  Patient falls at BART station due
130502 -            to fatigue, dizziness, shortness
130503 -            of breath; injures finger on left
130504 -            hand causing lymphedema on
130505 -            left arm to increase
130506 -            significantly.................... 060914, ref SDS 23 ZQ5I
130508 -             ..
130509 -       14.  Breathing difficult, heavy chest,
130510 -            tired; previously caused by
130511 -            pulmonary emboli, reported on
130512 -            041104, ref SDS 5 N43I, other
130513 -            side effects moderate - nausea
130514 -            queazy stomache solved eating
130515 -            small amounts food throughout
130516 -            the day.......................... 060929, ref SDS 24 QU8K
130518 -             ..
130519 -       15.  Pulmonary emboli recurrence
130520 -            diagnosed by CT test; Millie must
130521 -            resume treatment previously ended
130522 -            on 051007........................ 061002, ref SDS 26 MI5I
130524 -             ..
130525 -       16.  Fatigue, shortness of breath
130526 -            continues; less severe after
130527 -            starting treatment for pulmonary
130528 -            emboli........................... 061020, ref SDS 27 SK9O
130530 -             ..
130531 -       17.  Dry hands cracking and bleeding
130532 -            at cuticals...................... 061020, ref SDS 27 UM32
130534 -             ..
130535 -       18.  Nausea queasy stomache relieved
130536 -            by eating small amounts of
130537 -            food throughout the
130538 -            day.............................. 061020, ref SDS 27 D19M
130540 -             ..
130541 -       19.  Past few days coughing more than
130542 -            usual; also begun to clear throat
130543 -            noticably more often, similar to
130544 -            symptoms in 2004 that later were
130545 -            diagnosed as PE.................. 061108, ref SDS 29 VR6F
130547 -             ..
130548 -       20.  Fatigue, tired, shortness of
130549 -            breath, heavy chest with normal
130550 -            activity, dry hands, cracked,
130551 -            and bleeding, reported to
130552 -            Kaiser........................... 061110, ref SDS 30 SK9O
130554 -             ..
130555 -       21.  Fatigue, tired, shortness of
130556 -            breath, heavy chest with normal
130557 -            activity, dry hands, cracked,
130558 -            and bleeding, nails separating
130559 -            from fingers and toes, and eyes
130560 -            tearing, reported to
130561 -            Kaiser........................... 061201, ref SDS 31 SK9O
130563 -             ..
130564 -       22.  Millie feels very badly from
130565 -            side effects of chemotherapy
130566 -            beginning on Friday, 061201,
130567 -            with Taxotere, and continuing
130568 -            with capecitabine (Xeloda) for
130569 -            the next several
130570 -            weeks............................ 061204, ref SDS 32 F45O
130572 -             ..
130573 -       23.  Debilitating side effects of
130574 -            chemotherapy very difficult
130575 -            on 3rd and 4th days after
130576 -            treatment; Millie slept most
130577 -            of this time..................... 061205, ref SDS 33 343F
130579 -             ..
130580 -       24.  Cetuximab start new treatment no
130581 -            side effects, energy normal after
130582 -            treatment........................ 070201, ref SDS 34 QX8K
130584 -             ..
130585 -       25.  Millie has significantly increased
130586 -            energy, working out in the
130587 -            gym.............................. 070204, ref SDS 35 HF5H
130589 -             ..
130590 -       26.  Cetuximab 2nd treatment still no
130591 -            side effects of low energy,
130592 -            continues to feel
130593 -            stronger......................... 070208, ref SDS 36 F54N
130595 -             ..
130596 -       27.  Millie playing tennis, working out
130597 -            at the gym with increased energy
130598 -            and strength, indicating no side
130599 -            effects from cetuximab
130600 -            treatments....................... 070218, ref SDS 37 N05H
130602 -             ..
130603 -       28.  Cetuximab 5th treatment side
130604 -            effects of low energy seems to
130605 -            be occurring the past week or
130606 -            so; Millie starting to feel
130607 -            weaker........................... 070301, ref SDS 38 F54N
130609 -             ..
130610 -       29.  Cetuximab 6th treatment energy and
130611 -            strength recovering, eliminating
130612 -            side effects of low energy the
130613 -            week before Millie now feeling
130614 -            stronger......................... 070308, ref SDS 39 F54N
130616 -             ..
130617 -       30.  Cetuximab 9th treatment still no
130618 -            side effects of low energy,
130619 -            continues to feel
130620 -            stronger......................... 070329, ref SDS 40 F54N
130622 -             ..
130623 -       31.  IBC progression  of disease requires
130624 -            adding Carboplatin chemotherapy to
130625 -            cetuximab on clinical trial
130626 -            at UCSF.......................... 080219, ref SDS 41 3J4I
130628 -             ..
130629 -       32.  Worry stress anxiety about suffering
130630 -            debilitating side effects fatigue loss
130631 -            of energy reducing exercise ability
130632 -            to maintain blood counts cause
130633 -            significant emotional trauma about
130634 -            starting treatment adding
130635 -            chemotherapy Carboplatin to
130636 -            cetuximab........................ 080219, ref SDS 41 I35G
130638 -             ..
130639 -       33.  Worry about loss of energy and
130640 -            quality of life delays adding
130641 -            chemotherapy Carboplatin to
130642 -            clinical trial study
130643 -            regimen.......................... 080306, ref SDS 42 7V6M
130645 -             ..
130646 -       34.  Millie reported burst of energy
130647 -            after treatment with Carboplatin
130648 -            chemotherapy increasing exercise
130649 -            more than any time in the
130650 -            past 4 years..................... 080402, ref SDS 43 Q25V
130652 -             ..
130653 -       35.  Millie thrilled improvement recovering
130654 -            from IBC disease; energy and exercise
130655 -            have increased despite adding Carboplatin
130656 -            chemotherapy to cetuximab for the
130657 -            clinical trial regimen; reduced
130658 -            emotional trauma from stress,
130659 -            anxeity, doubt, and
130660 -            worry about the
130661 -            future........................... 080409, ref SDS 44 W14P
130662 -
130663 -
130664 -
130665 -
130666 -
130667 -
130668 -
130669 -
130670 -
130671 -
130672 -
130673 -
130674 -
130675 -
130676 -
1307 -